Bryce Carmine

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Bryce Carmine
Non-Executive Director / Kazia Therapeutics

Mr Carmine spent 36 years working for Eli Lilly & Co. and retired as Executive Vice President for Eli Lilly & Co, and President, Lilly Bio-Medicines. Prior to this he lead the Global Pharmaceutical Sales and Marketing and was a member of the company's Executive Committee. Mr Carmine previously held a series of product development portfolio leadership roles when he was named President, Global Pharmaceutical Product Development, with responsibility for the entire late-phase pipeline development across all therapeutic areas for Eli Lilly. During his career with Lilly, Bryce held several country leadership positions including President Eli Lilly Japan, Managing Dir. Australia/NZ & General Manager of a JV for Lilly in Seoul, Korea. Bryce is currently Chairman and CEO of HaemaLogiX Pty Ltd. He is Member of Risk and Governance Committee.

Lists and Charts

Knowledge Bank : Person Revenue

Rank Company #
894th - Kazia Therapeutics $3.39m
1219 public companies - non WA ranked by total revenue
View Full List

Share Transactions

13/03/23
$16.20k Bought
Kazia Therapeutics
03/03/23
$20.00k Bought
Kazia Therapeutics
06/09/22
$28.20k Bought
Kazia Therapeutics
Total value as at the date of the transaction
Powered by Morningstar ®

    Related Information

    Access to our data for Bryce Carmine is only available to paid subscribers with Data & Insights access.

    Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

    Bryce Carmine is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

    To see the data you will need to Subscribe.

    X